SCHEMBL2337022

SCHEMBL2337022

C/C(=C\C(C)CC(O)(C(F)(F)F)C(F)(F)F)C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL701312 1.00 MEN1 (0.33) MEN1KMT2A
SCHEMBL2401381 0.79 HTT (0.30)
SCHEMBL167527 0.76
SCHEMBL12275125 0.74
SCHEMBL12275130 0.74
SCHEMBL2333591 0.72 PDK1 (0.34)
SCHEMBL2333583 0.72 PDK1 (0.34)
SCHEMBL1839680 0.70 GRIK1 (0.31) MEN1KMT2A
SCHEMBL74357 0.70 GRIK1 (0.31) MEN1KMT2A
SCHEMBL2871424 0.70 GRIK1 (0.31) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802400-B2 Orientation control layer formed on a free top surface of a first block copolymer from a mixture of first and second block copolymers DOW GLOBAL TECHNOLOGIES LLC (US) 2017-10-31 US disclosed
US-9422445-B2 Sulfonamide-containing topcoat and photoresist additive compositions and methods of use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2016-08-23 US disclosed
US-20160053129-A1 Sulfonamide-Containing Topcoat and Photoresist Additive Compositions and Methods of Use CENTRAL GLASS CO., LTD. (JP) 2016-02-25 US disclosed
US-9223217-B2 Sulfonamide-containing topcoat and photoresist additive compositions and methods of use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-12-29 US disclosed
US-20140377518-A1 ORIENTATION CONTROL LAYER POLYMERS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2014-12-25 US disclosed
US-8728706-B2 Radiation-sensitive resin composition, method for forming resist pattern, polymer and polymerizable compound JSR CORPORATION (JP) 2014-05-20 US disclosed
US-20120237875-A1 RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYMER AND POLYMERIZABLE COMPOUND JSR CORPORATION (JP) 2012-09-20 US disclosed
US-20110207051-A1 Sulfonamide-Containing Topcoat and Photoresist Additive Compositions and Methods of Use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120237875-A1 RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYMER AND POLYMERIZABLE COMPOUND RER1, RDX, PRXL2A MEN1 4432/4885KMT2A 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.